These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25070750)

  • 1. How we approach an acquired thrombotic thrombocytopenic purpura patient.
    Raval JS; Mazepa MA; Brecher ME; Park YA
    Transfusion; 2014 Oct; 54(10):2375-82. PubMed ID: 25070750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P; Veyradier A
    Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
    Sarode R
    J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid ADAMTS13 availability impacts treatment for microangiopathic hemolytic anemia and thrombocytopenia.
    Martin IW; Katus MC; Martin CL; Szczepiorkowski ZM; Gorham JD; Dunbar NM
    J Clin Apher; 2016 Oct; 31(5):419-22. PubMed ID: 26332753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura in childhood: an uncommon but life-threatening cause of thrombocytopenia.
    Davis A; Barnes C
    J Paediatr Child Health; 2007 Sep; 43(9):640-2. PubMed ID: 17688649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
    Chai W; Chaudhry A; Rabinowitz AP
    J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
    Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
    J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
    Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
    Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
    Lowe EJ; Werner EJ
    Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
    J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and management of patients with thrombotic thrombocytopenic purpura.
    George JN
    J Intensive Care Med; 2007; 22(2):82-91. PubMed ID: 17456728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
    Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
    Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Robertson MD; Zumberg M
    Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpura.
    Cataland SR; Wu HM
    Semin Hematol; 2011 Oct; 48(4):242-50. PubMed ID: 22000089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.